Delta 9-tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis (1989)

Posted on by WOCredentials

“as THC has been shown to inhibit both clinical and histologic [experimental autoimmune encephalomyelitis], it may prove to be a new and relatively innocuous agent for the treatment of immune-mediated diseases.”

Lyman, W. D., Sonett, J. R., Brosnan, C. F., Elkin, R., & Bornstein, M. B. (1989). Δ9-Tetrahydrocannabinol: a novel treatment for experimental autoimmune encephalomyelitis. Journal of Neuroimmunology, 23(1), 73-81. DOI: 10.1016/0165-5728(89)90075-1

Read more…

Discover more from ContraReport

Subscribe to get the latest posts sent to your email.

Related Posts

Cannabis extract helps reset brain function in psychosis

“Research from King’s College London has found that a single dose of the cannabis extract cannabidiol can help reduce brain function abnormalities seen in people with psychosis.” Discover more from […]

One striking chart shows why pharma companies are fighting legal marijuana

“Our findings and existing clinical literature imply that patients respond to medical marijuana legislation as if there are clinical benefits to the drug, which adds to the growing body of […]

Cannabinoids and the immune system: an overview (2010)

“Cannabinoids can modulate immune reactions in the periphery but also in the brain, influence T cell subset balance and cytokine expression and play a role in the balance between neuroinflammation […]